RESUMEN
Prostate cancer (PCa) is the second most common type of cancer among men in the United States. A major limitation in the management of PCa is an inability to distinguish, early on, cancers that will progress and become life threatening. One-dimensional (1D) proton ((1)H) MRS of the prostate provides metabolic information such as levels of choline (Ch), creatine (Cr), citrate (Cit), and spermine (Spm) that can be used to detect and diagnose PCa. Ex vivo high-resolution magic angle spinning (HR-MAS) of PCa specimens has revealed detection of more metabolites such as myo-inositol (mI), glutamate (Glu), and glutamine (Gln). Due to the J-modulation and signal overlap, it is difficult to quantitate Spm and other resonances in the prostate clearly by single- and multivoxel-based 1D MR spectroscopy. This limitation can be minimized by adding at least one more spectral dimension by which resonances can be spread apart, thereby increasing the spectral dispersion. However, recording of multivoxel-based two-dimensional (2D) MRS such as J-resolved spectroscopy (JPRESS) and correlated spectroscopy (L-COSY) combined with 2D or three-dimensional (3D) magnetic resonance spectroscopic imaging (MRSI) using conventional phase-encoding can be prohibitively long to be included in a clinical protocol. To reduce the long acquisition time required for spatial encoding, the echo-planar spectroscopic imaging (EPSI) technique has been combined with correlated spectroscopy to give four-dimensional (4D) echo-planar correlated spectroscopic imaging (EP-COSI) as well as J-resolved spectroscopic imaging (EP-JRESI) and the multi-echo (ME) variants. Further acceleration can be achieved using non-uniform undersampling (NUS) and reconstruction using compressed sensing (CS). Earlier versions of 2D MRS, theory of 2D MRS, spectral apodization filters, newer developments and the potential role of multidimensional MRS in PCa detection and management will be reviewed here.
Asunto(s)
Diagnóstico por Imagen , Espectroscopía de Resonancia Magnética , Neoplasias de la Próstata/diagnóstico , Imagen Eco-Planar , Humanos , Masculino , Metaboloma , Próstata/metabolismoRESUMEN
Hepatic encephalopathy (HE) is normally diagnosed by neuropsychological (NP) tests. The goals of this study were to quantify cerebral metabolites, separate glutamate (Glu) from glutamine (Gln) in patients with minimal hepatic encephalopathy (MHE) as well as healthy subjects using the prior-knowledge fitting (ProFit) algorithm on data acquired by two-dimensional (2D) localized correlated spectroscopy (L-COSY) on two different MR scanners, and to correlate the metabolite changes with neuropsychological (NP) tests. We studied 14 MHE patients and 18 healthy controls using a GE 1.5 T Signa MR scanner. Another group of 16 MHE patients and 18 healthy controls were studied using a Siemens 1.5 T Avanto MR scanner. The following parameters were used for L-COSY: TR/TE = 2 s/30 ms, 3 × 3 × 3 cm(3) voxel size, 96 Δt(1) increments with 8 averages per Δt(1). Using the ProFit algorithm, we were able to differentiate Gln from Glu on the GE 1.5 T data in the medial frontal white/gray matter. The ratios of myo-inositol (mI), Glu, total choline, scyllo-inositol (sI), phosphoethanolamine (PE), and total N-acetyl aspartate (NAA) showed statistically significant decline in HE patients compared to healthy controls, while the ratio of Gln was significantly increased. Similar trend was seen in the ProFit quantified Siemens 1.5 T data in the frontal and occipito-parietal white/gray regions. Among the NP domain scores, motor function, cognitive speed, executive function and the global scores showed significant differences. Excellent correlations between various NP domains and metabolite ratios were also observed. ProFit based cerebral metabolite quantitation enhances the understanding and basis of the current hypothesis of MHE.
Asunto(s)
Ácido Glutámico/análisis , Glutamina/análisis , Encefalopatía Hepática/metabolismo , Espectroscopía de Resonancia Magnética/métodos , Adulto , Biomarcadores/metabolismo , Encéfalo/metabolismo , Química Encefálica , Estudios de Casos y Controles , Femenino , Encefalopatía Hepática/patología , Humanos , Procesamiento de Imagen Asistido por Computador/métodos , Masculino , Metaboloma , Persona de Mediana Edad , Pruebas Neuropsicológicas , Sensibilidad y EspecificidadRESUMEN
PURPOSE: To evaluate regional cerebral metabolic and structural changes in patients with minimal hepatic encephalopathy (MHE) using two-dimensional (2D) MR spectroscopy (MRS) and T( (1) )-weighted MRI, to correlate the observed MR changes with neuropsychological (NP) test scores, and to compare the diagnostic accuracy of MRI, 2D MRS, and NP tests in discriminating between patients and healthy subjects. MATERIALS AND METHODS: Thirty-three MHE patients and 30 healthy controls were investigated. The 2D localized correlated spectroscopy (L-COSY) was performed in the frontal and occipital brain on a 1.5 Tesla (T) MR scanner. The NP test battery included 15 tests, grouped into 6 cognitive domains. Globus pallidus signal intensities were calculated from T(1)-weighted images. RESULTS: The 2D MRS showed significant differences in ratios of the following metabolite(s) peaks with respect to creatine (Cr): decreased myo-inositol (mI), choline (Ch), mICh, and increased (glutamate plus glutamine) (Glx) in patients compared with healthy subjects in both occipital and frontal lobes. Frontal lobe taurine also showed a decline in patients. The NP test results revealed declines in cognitive speed, motor function, executive function, and global cognitive status. Significant correlations were found between the altered metabolites and NP tests. Alteration in the mICh/Cr ratio was noted as a powerful discriminant between healthy subjects and the patients. CONCLUSION: The study demonstrates that relative metabolite levels determined by 2D MRS, in particular mICh/Cr, provide the best diagnostic prediction for MHE. The results suggest that depletions of myo-inositol, choline and taurine with respect to creatine correlate with measures of neuropsychological impairment.
Asunto(s)
Encefalopatía Hepática/metabolismo , Espectroscopía de Resonancia Magnética/métodos , Pruebas Neuropsicológicas/estadística & datos numéricos , Femenino , Encefalopatía Hepática/patología , Humanos , Procesamiento de Imagen Asistido por Computador/métodos , Hígado/metabolismo , Hígado/patología , Masculino , Persona de Mediana Edad , Valor Predictivo de las Pruebas , Reproducibilidad de los Resultados , Sensibilidad y EspecificidadRESUMEN
PURPOSE: To evaluate T(2)-relaxation changes in patients with minimal hepatic encephalopathy (MHE) using T(2) relaxometry and to correlate T(2) values with brain metabolites evaluated using 2D magnetic resonance spectroscopy (MRS). MATERIALS AND METHODS: Eight MHE patients and 13 healthy subjects were evaluated using T(2) relaxometry, and eight patients and nine healthy subjects underwent 2D MRS in right frontal and left occipital regions. Whole-brain T(2)-relaxation maps were compared between MHE and control subjects using analysis-of-covariance, with age and gender included as covariates. T(2) values derived from the right frontal and left occipital lobes were correlated with the metabolite ratios. RESULTS: Multiple brain regions including anterior and mid cingulate cortices, right anterior and left posterior insular cortices, right prefrontal, medial frontal, and right superior temporal cortices showed significantly increased T(2) values in MHE patients compared to control subjects. MRS showed significantly increased ratios of glutamine/glutamate (Glx) and decreased ratios of myo-inositol, taurine, choline, and myo-inositol/choline (mICh) with respect to creatine (Cr_d) in patients compared to controls. Frontal Glx/Cr_d showed significantly positive correlation with T(2) values. CONCLUSION: MHE patients showed significantly increased T(2) values in multiple brain regions reflecting increased free water content and T(2) values in frontal lobe correlated with the increased Glx/Cr_d ratio.
Asunto(s)
Encéfalo/patología , Encefalopatía Hepática/patología , Hígado/patología , Imagen por Resonancia Magnética/métodos , Espectroscopía de Resonancia Magnética/métodos , Adulto , Anciano , Colina/metabolismo , Creatina/metabolismo , Femenino , Humanos , Inositol/metabolismo , Masculino , Persona de Mediana Edad , Taurina/metabolismoRESUMEN
Hepatic encephalopathy (HE) is normally diagnosed by neuropsychological (NP) tests, which are not very specific and do not reveal the underlying pathology. Magnetic resonance imaging (MRI) and spectroscopy (MRS) of the brain offer alternative and possibly more specific markers for HE. These methods were applied in conjunction with NP testing in order to determine their usefulness in the identification of HE and to understand the pathogenesis of HE more clearly. MR imaging and spectroscopy examinations, in addition to a battery of 15 NP tests, were administered to investigate 31 patients awaiting liver transplantation and 23 healthy controls. MR image intensities from the globus pallidus region were calculated and normalized to those of the thalamus. Absolute concentrations and ratios with respect to creatine (Cr) of several metabolites were computed from MR spectra. The MR data were correlated with the results of NP tests. The patients showed impairment in NP tests of attention and visuospatial and verbal fluency. In T1-weighted MRI, the relative intensity of the globus pallidus with respect to that of the thalamus region was significantly elevated in patients and correlated(negatively) with three NP tests (Hooper, FAS, and Trails B). The absolute concentrations of myo-inositol (mI) and choline (Ch) were significantly reduced in three brain regions. In addition, the absolute concentrations of glutamine (Gln) and combined glutamate and glutamine (Glx) were increased in all three locations, with Gln increase being significant in all areas while that of Glx only in the occipital white matter. In summary, this study partially confirms a hypothesized mechanism of HE pathogenesis, an increased synthesis of glutamine by brain glutamate in astrocytes due to excessive blood ammonia, followed by a compensatory loss of myo-inositol to maintain astrocyte volume homeostasis. It also indicates that the hyperintensity observed in globus pallidus could be used as complementary to the NP test scores in evaluating the mental health of HE patients.
Asunto(s)
Encéfalo/metabolismo , Encéfalo/patología , Encefalopatía Hepática/diagnóstico , Encefalopatía Hepática/metabolismo , Imagen por Resonancia Magnética , Espectroscopía de Resonancia Magnética , Pruebas Neuropsicológicas , Adulto , Anciano , Biomarcadores/metabolismo , Femenino , Encefalopatía Hepática/psicología , Humanos , Masculino , Persona de Mediana Edad , Proteínas del Tejido Nervioso/metabolismo , Reproducibilidad de los Resultados , Sensibilidad y Especificidad , Estadística como Asunto , Distribución TisularRESUMEN
The objective of this work was to evaluate the air kerma-area product (PKA) and the skin absorbed dose in the region of the eyes, salivary glands and thyroid of the patient from mandible examinations performed with three cone-beam computed tomography (CBCT) scanners, i.e. i-CAT classic, Gendex CB-500 and PreXion 3D. For the dosimetric evaluation, an anthropomorphic head phantom (model RS-250) was used to simulate an adult patient. The CBCT examinations were performed using standard and high-resolution protocols for mandible acquisitions for adult patients. During the phantom's exposure, the PKA was measured using an ionising chamber and the absorbed doses to the skin in the region of the eyes, thyroid and salivary glands were estimated using thermoluminescence dosemeters (TLDs) positioned on the phantom's surface. The PKA values estimated with the CBCT scanners varied from 26 to 138 µGy m(2). Skin absorbed doses in the region of the eyes varied from 0.07 to 0.34 mGy; at the parotid glands, from 1.31 to 5.93 mGy; at the submandibular glands, from 1.41 to 6.86 mGy; and at the thyroid, from 0.18 to 2.45 mGy. PKA and absorbed doses showed the highest values for the PreXion 3D scanner due to the use of the continuous exposure mode and a high current-time product.
Asunto(s)
Tomografía Computarizada de Haz Cónico/normas , Mandíbula/diagnóstico por imagen , Dosis de Radiación , Radiometría/normas , Aire , Antropometría , Tomografía Computarizada de Haz Cónico/métodos , Diseño de Equipo , Ojo/efectos de la radiación , Cabeza/efectos de la radiación , Humanos , Imagenología Tridimensional/métodos , Glándula Parótida/diagnóstico por imagen , Fantasmas de Imagen , Piel/efectos de la radiación , Glándula Submandibular/diagnóstico por imagen , Dosimetría Termoluminiscente/métodos , Glándula Tiroides/diagnóstico por imagen , Tomógrafos Computarizados por Rayos XRESUMEN
OBJECTIVE: Neuroanatomical abnormalities have been identified in patients with late-life mood disorders by using magnetic resonance imaging. This study examined the biochemical correlates of late-life major depression in the frontal gray and white matter by using single-voxel proton spectroscopy. METHOD: Twenty elderly patients with major depression and 18 comparison subjects similar in age and gender to the patients were scanned on a 1.5-T magnetic resonance scanner with head coil. Voxels were placed in the left dorsolateral white matter and bilaterally in the anterior cingulate gray matter. Absolute levels of N-acetylaspartate, choline, myo-inositol, and creatine were estimated with the LC-Model algorithm. Ratios of metabolite to creatine levels were computed from the absolute values. RESULTS: myo-Inositol/creatine and choline/creatine ratios were significantly higher in the frontal white matter in the major depression group than in the comparison group. The groups had no significant differences in the metabolite ratios in the gray matter. CONCLUSIONS: Biochemical changes in the white matter may provide some of the neurobiological substrates to late-life major depression.
Asunto(s)
Ácido Aspártico/análogos & derivados , Trastorno Depresivo Mayor/fisiopatología , Metabolismo Energético/fisiología , Lóbulo Frontal/fisiopatología , Espectroscopía de Resonancia Magnética , Anciano , Ácido Aspártico/metabolismo , Colina/metabolismo , Creatina/metabolismo , Trastorno Depresivo Mayor/diagnóstico , Dominancia Cerebral/fisiología , Femenino , Lóbulo Frontal/patología , Giro del Cíngulo/patología , Giro del Cíngulo/fisiopatología , Humanos , Inositol/metabolismo , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Corteza Prefrontal/patología , Corteza Prefrontal/fisiopatología , Escalas de Valoración Psiquiátrica , Valores de ReferenciaRESUMEN
The effects of ionizing radiation on Arabidopsis thaliana were investigated using 6 MV x-rays produced by a linear accelerator. Photosynthesis and respiration rates, chlorophyll fluorescence (fv/fm ratio and yield), plant height, total leaf area, stem mass, leaf mass, and above-ground biomass were measured to evaluate both physiological and physical impacts of ionizing radiation. The statistical analysis examined the radiation effects with respect to four different total doses (0.5 Gy, 5 Gy, 50 Gy, and 150 Gy), two different treatment types (single and fractionated), and irradiation at one of three different life stages (15 days, 20 days, and 25 days old). Results indicate that the age at the time of radiation exposure plays an important role in integrating radiation effects, and the irradiated A. thaliana indicated greater divergences in terms of physical growth compared to the internal physiological reactions. The results suggest that flowering plants like A. thaliana are capable of being utilized as a biodosimeter and further studies can be performed on specific areas, such as microscopic analysis of a plant's internal structure in order to assess the effects of ionizing radiation for a practical application.
Asunto(s)
Arabidopsis/efectos de la radiación , Arabidopsis/crecimiento & desarrollo , Arabidopsis/metabolismo , Aceleradores de Partículas , Fotosíntesis/fisiología , Fotosíntesis/efectos de la radiación , Hojas de la Planta/crecimiento & desarrollo , Hojas de la Planta/metabolismo , Hojas de la Planta/efectos de la radiación , Dosis de Radiación , Factores de Tiempo , Rayos XRESUMEN
PURPOSE: To quantify the changes in brain water diffusivity in hepatic encephalopathy (HE) associated with cirrhosis using diffusion tensor imaging (DTI) and to correlate with neuropsychological (NP) scores. MATERIALS AND METHODS: DTI was performed in 14 patients with low-grade HE and age/gender-comparable 16 healthy controls. Whole brain mean diffusivity (MD) and fractional anisotropy (FA) maps were calculated, normalized to common space, smoothed, and compared voxel-by-voxel between groups using analysis of covariance with age included as a covariate. The average MD and FA values were also calculated from individual subjects for selected brain regions and correlated with the neuropsychological scores. RESULTS: Patients with HE showed increased MD in the cortical gray and white matter and the internal capsule. Less extensive brain regions with decreased FA were observed in the bilateral frontal and occipital white matter. MD values from the corpus callosum correlated inversely with several NP scores among HE patients and controls. Positive correlations were observed with FA values and cognitive scores. CONCLUSION: Voxel-based DTI analysis showed widespread brain regions with increased MD values, indicating enhanced water content and decreased FA in cirrhotic patients with HE. The MD and FA values from selected regions correlated with the NP scores.
Asunto(s)
Edema Encefálico/diagnóstico , Edema Encefálico/etiología , Imagen de Difusión por Resonancia Magnética/métodos , Encefalopatía Hepática/complicaciones , Adulto , Anciano , Edema Encefálico/fisiopatología , Estudios de Casos y Controles , Femenino , Encefalopatía Hepática/psicología , Humanos , Masculino , Persona de Mediana Edad , Pruebas Neuropsicológicas , PsicometríaRESUMEN
PURPOSE: To evaluate a localized two-dimensional correlated magnetic resonance spectroscopic (L-COSY) technique in patients with hepatic encephalopathy (HE) and healthy subjects, and to correlate the cerebral metabolite changes with neuropsychological (NP) test scores. MATERIALS AND METHODS: Eighteen minimal hepatic encephalopathy (MHE) patients and 21 healthy controls have been investigated. A GE 1.5-T magnetic resonance (MR) scanner was used in combination with a body MR coil for transmission and a 3-inch surface coil for reception. A 27-mL voxel was localized by three slice-selective radio frequency (RF) pulses (90 degrees-180 degrees-90 degrees) in the anterior cingulate region. The total duration of each two-dimensional L-COSY spectrum was approximately 25 minutes. The NP battery included a total of 15 tests, which were grouped into six domains. RESULTS: MR spectroscopic results showed a statistically significant decrease in myo-inositol (mI) and choline (Ch) and an increase in glutamate/glutamine (Glx) in patients when compared to healthy controls. There was also an increase in taurine (Tau) in patients. The NP results indicated a significant correlation between motor function assessed by NP tests and mI ratios recorded using two-dimensional L-COSY. CONCLUSION: The study demonstrated the feasibility of evaluating the two-dimensional L-COSY sequence in a clinical environment. The results showed additional cerebral metabolites that can be measured with the technique in comparison to one-dimensional study.